Over 90% of disease associated single nucleotide polymorphisms (SNPs) identified by genome wide association studies (GWAS) are noncoding variants. Platform to efficiently validate the biological funct
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications Descriptor: Insulin, ZINC ION Authors: Zhao, M, Wan, Z.L, Whittaker, L, Xu, B
Global Insulin Biosimilars Market size was valued at USD 2.67 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 4.07 billion by 2031, growing at a CAGR of 4.8% in the forecast
Diabetes mellitus is a growing problem worldwide; however, only 23% of low-income countries have access to insulin, and ironically it costs higher in such countries than high-income ones. Therefore, n